Cerebral vasoreactivity in Parkinson’s disease and multiple system atrophy: A pilot study
Objective: To compare cerebral vasoreactivity in Parkinson´s disease (PD) and multiple system atrophy (MSA) patients with or without cardiovascular autonomic failure (CAF). Background: CAF is…Orthostatic intolerance and falls in Parkinson’s disease
Objective: Primary objective: to assess the relationship between falls, orthostatic intolerance and orthostatic hypotension (OH) in patients with Parkinson's disease (PD). Secondary objective: to assess…RBD increase non-motor symptom in Parkinson’s disease
Objective: To investigate the relationship between the RBD and other non-motor symptoms in Parkinson's disase. Background: Rapid eye movement sleep behavior disorder (RBD) is frequent…Prevalence and risk factors of orthostatic hypotension in Thai Parkinson’s disease patients
Objective: To determine the prevalence of OH and identify risk factors associated with OH in Thai PD patients. Background: Orthostatic hypotension (OH) represents one of…Prevalence and risk factors for orthostatic hypotension in early PD
Objective: To identify the prevalence of orthostatic hypotension (OH) in early Parkinson's disease (PD) and identify clinical features associated with greater postural drop in BP…Cognitive and behavioral side effects in patients treated with droxidopa for neurogenic orthostatic hypotension
Objective: To describe adverse behavioral symptoms attributed to droxidopa therapy for neurogenic orthostatic hypotension (nOH). Background: Droxidopa, a norepinephrine (NE) precursor, improves symptoms of neurogenic…Prevalence of orthostatic hypotension after a low subacute levodopa dose in patients with parkinsonism
Objective: To evaluate the prevalence of orthostatic hypotension (OH) after a low subacute levodopa (LD) dose in patients with diagnosis of Parkinson's disease (PD) or…
- « Previous Page
- 1
- …
- 6
- 7
- 8